Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Disease to Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04364724
What this trial is testing

CTFEA Myeloma Study

Who this might be right for
Myeloma MultipleMetastatic Bone Tumor
Tel-Aviv Sourasky Medical Center 200
Not applicableActive Not RecruitingNCT05461313
What this trial is testing

Fully Constrained Acetabular Liner vs. Dual Mobility Hip Joint in the Surgical Treatment of Metastatic Bone Disease of the Hip

Who this might be right for
Metastatic Cancer to the Hip
Rigshospitalet, Denmark 146
Post-approval studies (Phase 4)Ended earlyNCT03029442
What this trial is testing

The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury

Who this might be right for
Secondary OsteoporosisSpinal Cord Injury
James J. Peters Veterans Affairs Medical Center 5
Large-scale testing (Phase 3)Study completedNCT00321620
What this trial is testing

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer

Who this might be right for
Bone Metastases
Amgen 1,904
Not applicableLooking for participantsNCT05904353
What this trial is testing

Improve the Collaboration Between Primary and Secondary Health Care on the Treatment of Osteoporosis After a Hip Fracture.

Who this might be right for
Hip FracturesOsteoporosisZoledronic Acid+2 more
University Hospital, Akershus 200
Testing effectiveness (Phase 2)Study completedNCT04232657
What this trial is testing

Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI

Who this might be right for
Spinal Cord Injury (=3 Years)Sublesional Bone Loss Secondary to SCI
VA Office of Research and Development 36
Not applicableStudy completedNCT00335751
What this trial is testing

PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Jonsson Comprehensive Cancer Center 120
Not applicableUnknownNCT06321666
What this trial is testing

Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone

Who this might be right for
Metastatic Breast Cancer
European Institute of Oncology 58
Testing effectiveness (Phase 2)Study completedNCT02924376
What this trial is testing

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Who this might be right for
Cholangiocarcinoma
Incyte Corporation 147
Large-scale testing (Phase 3)Study completedNCT00004208
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Swiss Cancer Institute 86
Testing effectiveness (Phase 2)Study completedNCT00554918
What this trial is testing

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
University Hospital Birmingham 300
Not applicableStudy completedNCT05038124
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone

Who this might be right for
Metastatic Cancer
Memorial Sloan Kettering Cancer Center 39
Large-scale testing (Phase 3)Study completedNCT01231906
What this trial is testing

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Who this might be right for
Localized Extraskeletal Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor of BonePeripheral Primitive Neuroectodermal Tumor of Soft Tissues
Children's Oncology Group 642
Early research (Phase 1)Looking for participantsNCT07087197
What this trial is testing

SKB107 in Advanced Solid Tumors With Bone Metastases

Who this might be right for
Metastatic Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 90
Not applicableStudy completedNCT03847220
What this trial is testing

Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

Who this might be right for
Breast Carcinoma Metastatic to the Bone
Spanish Breast Cancer Research Group 241
Not applicableWithdrawnNCT02465723
What this trial is testing

Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers

Who this might be right for
Metastatic Disease to BoneMetastatic Disease to Soft Tissue
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00869206
What this trial is testing

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Who this might be right for
Breast AdenocarcinomaDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell Myeloma+4 more
Alliance for Clinical Trials in Oncology 1,822
Early research (Phase 1)Looking for participantsNCT07194044
What this trial is testing

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

Who this might be right for
Metastatic Ewing Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT00077116
What this trial is testing

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 31
Testing effectiveness (Phase 2)Ended earlyNCT01816048
What this trial is testing

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Who this might be right for
Prostatic NeoplasmsProstate Cancer
University of Wisconsin, Madison 8
Next Page